CIK 0001585364
- Large accelerated filer
PERRIGO Co plc
Sign in to watch- Ticker
- PRGO
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +1 269-673-8451
- Business address
- THE SHARP BUILDING, HOGAN PLACE, DUBLIN 2, Ireland, D02 TY74
- Former names
- PERRIGO Co Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-04 | Dillard James E III EVP & President CSCA | Option exercise · Restricted Stock Units | −2,681 | 5,360 | ||
| 2022-03-04 | Quinn Grainne EVP, Chief Medical Officer | Grant or award | +6,008 | $37.23 | $224K | 12,759 |
| 2022-03-04 | Quinn Grainne EVP, Chief Medical Officer | Shares withheld for taxes | −3,125 | $37.23 | $116K | 9,634 |
| 2022-03-04 | Quinn Grainne EVP, Chief Medical Officer | Option exercise | +1,226 | $37.23 | $46K | 10,860 |
| 2022-03-04 | Quinn Grainne EVP, Chief Medical Officer | Shares withheld for taxes | −638 | $37.23 | $24K | 10,222 |
| 2022-03-04 | Quinn Grainne EVP, Chief Medical Officer | Option exercise | +1,052 | $37.23 | $39K | 11,274 |
| 2022-03-04 | Quinn Grainne EVP, Chief Medical Officer | Shares withheld for taxes | −548 | $37.23 | $20K | 10,726 |
| 2022-03-04 | Quinn Grainne EVP, Chief Medical Officer | Option exercise | +1,584 | $37.23 | $59K | 12,310 |
| 2022-03-04 | Quinn Grainne EVP, Chief Medical Officer | Shares withheld for taxes | −824 | $37.23 | $31K | 11,486 |
| 2022-03-04 | Quinn Grainne EVP, Chief Medical Officer | Option exercise · Restricted Stock Units | −1,226 | 0 | ||
| 2022-03-04 | Quinn Grainne EVP, Chief Medical Officer | Option exercise · Restricted Stock Units | −1,052 | 1,052 | ||
| 2022-03-04 | Quinn Grainne EVP, Chief Medical Officer | Option exercise · Restricted Stock Units | −1,584 | 3,167 | ||
| 2022-03-04 | KESSLER MURRAY S CEO | Grant or award | +80,286 | $37.23 | $3.0M | 123,768 |
| 2022-03-04 | KESSLER MURRAY S CEO | Shares withheld for taxes | −34,341 | $37.23 | $1.3M | 89,427 |
| 2022-03-04 | KESSLER MURRAY S CEO | Option exercise | +16,384 | $37.23 | $610K | 105,811 |
| 2022-03-04 | KESSLER MURRAY S CEO | Shares withheld for taxes | −6,063 | $37.23 | $226K | 99,748 |
| 2022-03-04 | KESSLER MURRAY S CEO | Option exercise | +14,060 | $37.23 | $523K | 113,808 |
| 2022-03-04 | KESSLER MURRAY S CEO | Shares withheld for taxes | −5,203 | $37.23 | $194K | 108,605 |
| 2022-03-04 | KESSLER MURRAY S CEO | Option exercise | +18,884 | $37.23 | $703K | 127,489 |
| 2022-03-04 | KESSLER MURRAY S CEO | Shares withheld for taxes | −6,988 | $37.23 | $260K | 120,501 |
Page 36 of 47 · 921 trades